Edition:
United Kingdom

People: Cadila Healthcare Ltd (CADI.NS)

CADI.NS on National Stock Exchange of India

385.10INR
8:58am BST
Change (% chg)

Rs2.25 (+0.59%)
Prev Close
Rs382.85
Open
Rs383.90
Day's High
Rs387.40
Day's Low
Rs381.50
Volume
987,194
Avg. Vol
2,332,015
52-wk High
Rs515.00
52-wk Low
Rs332.75

Patel, Pankaj 

Shri. Pankaj Ramanbhai Patel serves as Executive Chairman of the Board of the Company. He was Executive Chairman of the Board, Managing Director of Cadila Healthcare Ltd. Mr. Pankaj Patel, M. Pharm., spearheads Zydus Cadila, one of India’s pharmaceutical groups and a global healthcare provider. With an experience spanning over 30 years in the Indian Pharmaceuticals industry, Mr. Patel combines both research and techno-commercial experience. Mr. Patel has been the guiding force behind Company’s fast tracked growth. Under his leadership, recently, the Company was declared as the “Emerging Company of the Year” by the Economic Times for Corporate Excellence in 2010. Mr. Patel is on the governing councils of many national industry associations. Mr. Patel is the President of the Indian Pharmaceutical Alliance and the Chairman of FICCI, Gujarat State Council. He is the Executive Chairman, Vice President and Trustee of Gujarat Cancer Society and Chairman of Gujarat Cancer and Research Institute. He is also on the Governing Board of the Ahmedabad University and the President of the Ahmedabad Management Association. Mr. Patel was awarded the E&Y Entrepreneur of the Year – Life Sciences Award for the year 2009, the M. L. Schroff Memorial Award in 2009 and “Baroda Sun Lifetime Achievement Award” for the year 2010 by the Bank of Baroda. Mr. Patel was declared “Pharma Man of the Year” in 2004 by the Federation of Indian Industry and Economists [FIIE] for contributing to the growth of the Indian Pharma Industry. Recently, Mr. Patel was conferred the Indian Pharmaceutical Association’s “Special Recognition Award 2010” in recognition of his contributions to the growth of the Pharmaceutical Industry, Research and the Profession of Pharmacy.

Basic Compensation

Total Annual Compensation, INR 180,000,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 180,000,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Pankaj Patel

180,000,000

Nitin Parekh

33,325,000

Ganesh Nayak

--

Upen Shah

3,359,000

Sharvil Patel

120,000,000

Mukesh Patel

3,900,000
As Of  31 Mar 2017